Recombinant Human KLK9 Protein，His

KLK9, or Kallikrein-related peptidase 9, is a member of the kallikrein family of serine proteases that plays a significant role in various physiological and pathological processes, including tissue remodeling, inflammation, and cancer progression. Studies have shown that KLK9 is differentially expressed in various cancer types, particularly in prostate cancer, where it has been implicated in tumor growth and metastasis. The ability of KLK9 to cleave specific substrates suggests it may be involved in the activation of growth factors or other proteases, highlighting its potential role in the tumor microenvironment. Furthermore, KLK9's expression levels and enzymatic activity may serve as biomarkers for cancer diagnosis and prognosis. Given its importance in cancer biology, researchers have turned towards the production of recombinant KLK9 proteins to elucidate its biological functions and mechanisms of action. The recombinant protein can be utilized in in vitro studies to investigate its enzymatic activity, substrate specificity, and potential interactions with various signaling pathways. Moreover, generating KLK9 as a recombinant protein provides opportunities to explore its therapeutic applications, particularly in developing targeted therapies that aim to inhibit its activity in tumor progression. Understanding the functional roles of KLK9 through recombinant research may contribute to the development of novel diagnostic tools and treatment strategies in oncology, making it an important focus of contemporary biomedical research.